valsartan has been researched along with vericiguat in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aimo, A; Bayes-Genis, A; Emdin, M; Georgiopoulos, G; Lombardi, CM; Passino, C; Pateras, K; Stamatelopoulos, K | 1 |
| Felker, GM; Mann, DL | 1 |
| Gronda, E; Iacoviello, M; Palazzuoli, A | 1 |
| Gallo, G; Rubattu, S; Volpe, M | 1 |
| Grimm, D; Norre, T; Simonsen, U | 1 |
| Alemayehu, WG; Armstrong, PW; Butler, J; Edelmann, F; Ezekowitz, J; Hernandez, AF; Lam, CSP; McMullan, C; O'Connor, CM; Pieske, B; Ponikowski, P; Roessig, L; Senni, M; Sim, D; Voors, AA; Westerhout, CM | 1 |
| Butt, JH; McMurray, JJV | 1 |
4 review(s) available for valsartan and vericiguat
| Article | Year |
|---|---|
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Clinical Trials, Phase III as Topic; Drug Combinations; Heart Failure; Heterocyclic Compounds, 2-Ring; Hospitalization; Humans; Network Meta-Analysis; Pyrimidines; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Valsartan | 2021 |
Mechanisms and Models in Heart Failure: A Translational Approach.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Development; Enzyme Activators; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Models, Biological; Natriuretic Peptides; Neprilysin; Pyrimidines; Sodium-Glucose Transporter 2 Inhibitors; Soluble Guanylyl Cyclase; Stroke Volume; Urea; Valsartan; Ventricular Remodeling | 2021 |
Recent advances in pharmacological treatment of heart failure.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiotonic Agents; Drug Combinations; Ferric Compounds; Heart Failure; Heterocyclic Compounds, 2-Ring; Hospitalization; Humans; Iron Deficiencies; Maltose; Pyrimidines; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Urea; Valsartan; Vasodilator Agents; Ventricular Remodeling | 2021 |
Sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Glucose; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Pyrimidines; Sodium; Tetrazoles; Treatment Outcome; Valsartan | 2022 |
1 trial(s) available for valsartan and vericiguat
| Article | Year |
|---|---|
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial.
Topics: Aminobutyrates; Biphenyl Compounds; Drug Combinations; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Hyperkalemia; Hypotension; Pyrimidines; Stroke Volume; Treatment Outcome; Valsartan; Ventricular Dysfunction, Left | 2022 |
2 other study(ies) available for valsartan and vericiguat
| Article | Year |
|---|---|
Targeting Cyclic Guanylate Monophosphate in Resistant Hypertension and Heart Failure: Are Sacubitril/Valsartan and Vericiguat Synergistic and Effective in Both Conditions?
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Hypertension; Neprilysin; Pyrimidines; Stroke Volume; Tetrazoles; Valsartan | 2021 |
Vericiguat, sacubitril/valsartan and more evidence that we are failing our patients.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Pyrimidines; Stroke Volume; Tetrazoles; Valsartan | 2022 |